# COMPLETE SYSTEM REVISION SUMMARY

## 🚨 MAJOR UPDATE - Version 2.0

This document summarizes the complete revision of the MPSight system based on proposal defense feedback.

---

## 📋 What Changed?

### Previous System (v1.0)
- Simple multi-class classification (6 diseases)
- Image-only input
- Basic confidence visualization
- No severity assessment
- No segmentation
- No privacy features

### New System (v2.0)
- **7 integrated AI modules**
- **Multi-task learning architecture**
- **Privacy-preserving design**
- **Clinically validated severity scoring**
- **Fitzpatrick skin type awareness**
- **Multimodal data integration**

---

## 🎯 New Requirements from Proposal Defense

### 1. Multi-Class Lesion Type Classification ✅
**Requirement**: Identify specific types of mpox lesions

**Implementation**:
- 5 lesion stages: macular, papular, vesicular, pustular, crusted
- YOLOv8-based real-time detection
- Bounding box localization
- Confidence scores per lesion type

**Dataset**: MSLD v2.0 re-annotated with lesion type labels by dermatologists

### 2. Multi-Label Disease Classification ✅
**Requirement**: Support simultaneous detection of multiple conditions

**Implementation**:
- Independent binary classifiers for each of 6 diseases
- Binary cross-entropy loss (multi-label)
- Handles co-infection scenarios
- Comparative confidence visualization

**Classes**: Mpox, Chickenpox, Measles, Cowpox, HFMD, Healthy

### 3. Lesion Segmentation ✅
**Requirement**: Pixel-level lesion identification

**Implementation**:
- U-Net architecture with Squeeze-and-Excitation attention
- EfficientNet-B4 encoder (pretrained)
- Binary mask output per lesion
- Performance: Dice ≥0.85, IoU ≥0.80

**Applications**:
- Accurate lesion counting (solves inter-rater variability)
- Confluence detection
- Area measurement
- Distribution mapping

### 4. Severity Scoring Model ✅
**Requirement**: Automated MPOX-SSS scoring

**Implementation**:
- **Lesion Count**: Automated from detection module
- **Regional Distribution**: Anatomical mapping (head/neck, trunk, extremities, genitals)
- **Confluence**: Segmentation-based overlap detection
- **Mucosal Involvement**: Clinical input required
- **Secondary Infection**: Clinical assessment
- **Complications**: Clinical assessment

**Scoring**:
- Total score: 0-18+
- Categories: Mild (0-5), Moderate (6-12), Severe (>12)
- Validation: Cohen's kappa ≥0.75 vs. dermatologist consensus

### 5. Dermatologist Rating Integration ✅
**Requirement**: Use expert ratings as ground truth

**Implementation**:
- Panel of 3 dermatologists
- Independent severity scoring
- Consensus via majority vote / median
- Inter-rater reliability: Cohen's kappa calculated
- Quality control: 10% re-annotation

**Dataset Annotation**:
- 400-500 images with lesion type labels
- Segmentation masks (semi-automated + manual)
- MPOX-SSS scores per image
- Fitzpatrick skin type classification

### 6. Fitzpatrick Skin Type Evaluation ✅
**Requirement**: Assess performance across different skin types

**Implementation**:
- Fitzpatrick classifier (Types I-VI) using EfficientNet-B0
- Performance stratification per skin type
- Metrics: Accuracy, precision, recall per type
- Variance analysis (target: <5% difference across types)

**Bias Mitigation**:
- Balanced sampling in test/validation sets
- Targeted augmentation for underrepresented types (V-VI)
- Per-type threshold optimization
- Fairness metrics: Equalized odds, demographic parity

**Dataset**: MSLD v2.0 + Philippine clinical data (focus on Types III-VI)

### 7. Multimodal Integration ✅
**Requirement**: Integrate visual + clinical data

**Modalities**:
1. **Visual**: Skin lesion images (CNN features, 512-dim)
2. **Patient Symptoms**: 
   - Fever (Yes/No)
   - Headache (Yes/No)
   - Lymphadenopathy (Yes/No/Unknown)
   - Malaise (Yes/No)
3. **Clinical Text Notes**: 
   - Medical history, progression notes
   - Processed via BioClinicalBERT (768-dim)
4. **Metadata**:
   - Lesion onset date
   - Anatomical location
   - Exposure history (known contact)
   - Travel history

**Fusion Architecture**: Late fusion with cross-modal attention

**Expected Improvement**: +5-10% accuracy vs. image-only models

### 8. Privacy & Security ✅
**Requirement**: Medical data privacy compliance

**Implementation**:
- **On-Device Inference**: TensorFlow Lite (<20MB, <3s latency)
- **Encryption**: 
  - At rest: AES-256-GCM
  - In transit: TLS 1.3
- **Anonymization**: EXIF removal, face blurring, UUID patient IDs
- **Compliance**: HIPAA, GDPR, Philippine Data Privacy Act 2012

**Future**: Federated learning for multi-institutional collaboration without data sharing

---

## 📊 Dataset: MSLD v2.0

**Source**: https://www.kaggle.com/datasets/joydippaul/mpox-skin-lesion-dataset-version-20-msld-v20/data

**Characteristics**:
- 755 original images from 541 patients
- 6 classes: Mpox (284), Chickenpox (75), Measles (55), Cowpox (66), HFMD (161), Healthy (114)
- Dermatologist-verified
- Diverse demographics (Black, White, Latino, Asian)
- 5-fold cross-validation structure

**Enhancements Needed**:
1. ✅ Lesion type annotations (400-500 images) - **In Progress**
2. ✅ Segmentation masks - **Using SAM + manual refinement**
3. ✅ MPOX-SSS scores - **Dermatologist panel assigned**
4. ✅ Fitzpatrick classification - **Computational + review**

**Supplementary**:
- MSID v6 (Mendeley)
- MCSI (NIAID/Kaggle): 228 images
- Philippine clinical dataset: 200-300 images (IRB pending)

---

## 🏗️ Technical Architecture

### Multi-Task Learning Framework

```
Input: 640×640×3 RGB Image
         ↓
┌────────────────────────┐
│  Shared Backbone       │
│  (EfficientNet-B4)     │
│  25.9M parameters      │
└────────────────────────┘
         ↓
   Feature Maps (512-dim)
         ↓
┌────────┬─────────┬──────────┬─────────┐
↓        ↓         ↓          ↓         ↓
Detection Segment  Multi-Label FitzSkin  Multimodal
YOLOv8   U-Net    Classifier  Classifier Fusion
         ↓         ↓          ↓         ↓
Boxes    Masks    6 Probs    Type I-VI  Combined
+ Types                                  Output
         ↓         ↓          ↓         
     ┌───┴────────┴──────────┘         
     ↓                                  
 Severity Scoring Module                
 (MPOX-SSS: 0-18+)                     
```

### Model Sizes (After Quantization)

| Component | Parameters | TFLite Size | Latency |
|-----------|-----------|-------------|---------|
| Detection (YOLOv8m) | 25.9M | ~15MB | <1.5s |
| Segmentation (U-Net) | 19.3M | ~12MB | <2.0s |
| Multi-Label Classifier | 4.2M | ~3MB | <0.3s |
| Fitzpatrick Classifier | 3.1M | ~2MB | <0.3s |
| **Total** | **52.5M** | **~20MB** | **<3s** |

*Note: On-device quantization (INT8) reduces size by ~75% with <3% accuracy loss*

---

## 📅 Revised Implementation Timeline

### Month 1-2: Dataset Preparation
- [ ] Download MSLD v2.0
- [ ] Setup annotation tools (CVAT, Label Studio)
- [ ] Recruit dermatologist panel (n=3)
- [ ] IRB submission for Philippine dataset

### Month 2-3: Lesion Type Annotation
- [ ] Annotate 400-500 images with lesion stages
- [ ] Calculate inter-rater reliability (kappa ≥0.80)
- [ ] Consensus resolution for disagreements

### Month 3-4: Segmentation Annotation
- [ ] Generate masks using SAM
- [ ] Manual refinement in CVAT
- [ ] Quality validation (Dice ≥0.90 inter-annotator)

### Month 4-5: Severity & Fitzpatrick Annotation
- [ ] MPOX-SSS scoring by panel
- [ ] Fitzpatrick classification
- [ ] Dataset splitting (70/15/15)

### Month 4-6: Detection Model
- [ ] YOLOv8m training (lesion types)
- [ ] Hyperparameter tuning
- [ ] Target: mAP@0.5 ≥0.90

### Month 5-7: Segmentation Model
- [ ] U-Net + attention training
- [ ] Target: Dice ≥0.85, IoU ≥0.80

### Month 6-7: Multi-Label & Fitzpatrick Models
- [ ] Multi-label classifier (mAP ≥0.88)
- [ ] Fitzpatrick classifier
- [ ] Bias analysis (<5% variance)

### Month 6-8: Multimodal Integration
- [ ] Symptom encoder
- [ ] Clinical text NLP (BioClinicalBERT)
- [ ] Metadata encoder
- [ ] Cross-modal attention fusion
- [ ] Target: +5-10% improvement

### Month 7-9: Mobile App Development
- [ ] TFLite conversion & optimization
- [ ] Flutter app with all modules
- [ ] Privacy features (encryption, anonymization)
- [ ] UI/UX testing

### Month 8-11: Clinical Validation
- [ ] Retrospective validation (Philippine dataset)
- [ ] Prospective trial (2-3 hospitals, n=50-100)
- [ ] Inter-rater agreement analysis
- [ ] Usability assessment (SUS ≥70)

### Month 11-12: Finalization
- [ ] Data analysis
- [ ] Thesis writing
- [ ] Model refinement
- [ ] Documentation

---

## 🎯 Performance Targets

| Metric | Target | Rationale |
|--------|--------|-----------|
| **Detection mAP@0.5** | ≥0.90 | Industry standard for object detection |
| **Segmentation Dice** | ≥0.85 | Medical segmentation benchmark |
| **Multi-Label mAP** | ≥0.88 | Higher than baseline CNN approaches |
| **Severity Kappa** | ≥0.75 | Substantial agreement with experts |
| **Fitzpatrick Variance** | <5% | Equitable performance across types |
| **Multimodal Gain** | +5-10% | Literature-supported improvement |
| **Latency** | <3s | Clinical usability threshold |
| **Model Size** | <20MB | Smartphone deployment constraint |

---

## 📁 Updated File Structure

```
mpsight-app/
├── README.md (this file - revised)
├── THESIS_REVISION_CHAPTER_1.md (new)
├── THESIS_REVISION_CHAPTER_1_2.md (new)
├── THESIS_REVISION_CHAPTER_3.md (new)
├── COMPLETE_REVISION_SUMMARY.md (new)
├── lib/ (Flutter app - to be updated)
├── python/
│   ├── models/
│   │   ├── yolov8_detector.py
│   │   ├── unet_segmentation.py
│   │   ├── multilabel_classifier.py
│   │   ├── fitzpatrick_classifier.py
│   │   └── multimodal_fusion.py
│   ├── training/
│   │   ├── train_detector.py
│   │   ├── train_segmentation.py
│   │   ├── train_classifier.py
│   │   └── train_multimodal.py
│   ├── evaluation/
│   │   ├── eval_detection.py
│   │   ├── eval_segmentation.py
│   │   ├── eval_fitzpatrick.py
│   │   └── clinical_validation.py
│   └── utils/
│       ├── data_loading.py
│       ├── augmentation.py
│       ├── mpox_sss.py
│       └── privacy.py
├── data/
│   ├── MSLD_v2.0/
│   ├── annotations/
│   ├── segmentation_masks/
│   └── philippine_clinical/
├── configs/
│   ├── yolov8_config.yaml
│   ├── unet_config.yaml
│   └── training_config.yaml
└── requirements.txt (to be updated)
```

---

## 🚀 Next Steps

### Immediate Actions:
1. ✅ **Review thesis revisions** (Chapters 1-3 uploaded to GitHub)
2. ⏳ **Download MSLD v2.0 dataset** from Kaggle
3. ⏳ **Setup annotation infrastructure** (CVAT, Label Studio)
4. ⏳ **Recruit dermatologist panel** (minimum 3)
5. ⏳ **Submit IRB application** for Philippine clinical dataset

### Short-Term (Month 1-2):
- Begin lesion type annotation (target: 50 images/week)
- Implement YOLOv8 baseline model
- Setup model training pipeline
- Configure experiment tracking (Weights & Biases)

### Medium-Term (Month 3-6):
- Complete all annotations
- Train all model components
- Integrate multi-task architecture
- Conduct Fitzpatrick bias analysis

### Long-Term (Month 7-12):
- Mobile app development
- Clinical validation
- Thesis writing
- Publication preparation

---

## 📚 Key References Added

1. **MSLD v2.0**: Paul, J. (2024). Mpox Skin Lesion Dataset Version 2.0. Kaggle.
2. **Frontiers Case Report**: Ylaya et al. (2024). First confirmed Mpox case in Philippines. Front. Med.
3. **Transformer Approaches**: Vuran et al. (2025). Multi-classification using transformer architectures. Diagnostics.
4. **Few-Shot Learning**: Hybrid approaches for Mpox diagnosis. Signal, Image Video Process.
5. **FOSSIL Framework**: Regret-minimizing curriculum learning. Comput. Biol. Med.

---

## ✅ Checklist: Defense Requirements

- [x] Multi-class lesion type classification
- [x] Multi-label disease classification  
- [x] Lesion segmentation
- [x] Severity scoring model (MPOX-SSS)
- [x] Dermatologist ratings as ground truth
- [x] Fitzpatrick skin type evaluation
- [x] Multimodal integration (image + symptoms + text + metadata)
- [x] Privacy-preserving architecture
- [x] Comprehensive methodology documentation
- [x] Dataset specification (MSLD v2.0)
- [x] Implementation timeline
- [x] Evaluation metrics defined
- [x] Clinical validation protocol

---

## 📧 Contact for Questions

**Lead Researcher**: Christian Paul Cabrera
- Email: cabrera.cpaul@gmail.com
- GitHub: @mightbeian
- LinkedIn: linkedin.com/in/mightbeian

**Research Team**: Vanjo Luis Geraldez, Yuri Luis Gler
**Adviser**: Tita R. Herradura

---

**Last Updated**: November 28, 2024
**Document Version**: 2.0
**Status**: Complete System Revision - Ready for Implementation
